3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 3
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
7
Colonic Neoplasms
6
Recurrence
4
Prostatic Neoplasms
4
Neoplasms
4
Polycythemia Vera
3
Venous Thromboembolism
2
Thrombocythemia, Essential
2
Rectal Neoplasms
2
Myocardial Infarction
2
Esophageal Neoplasms
2
Cardiovascular Diseases
2
Adenoma
2
Vascular Diseases
1
Thrombosis
1
Thrombocytopenia
1
Stomach Neoplasms
1
Primary Myelofibrosis
1
Precancerous Conditions
1
Pathologic Processes
1
Node Positive HER2 Negative Breast Cancer
1
Neoplasms by Site
1
Neoplasm Metastasis
1
Myocardial Ischemia
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Lynch syndrome I (site-specific colonic cancer)
1
Lymphoma, Follicular
1
Liver Cirrhosis
1
Ischemic Stroke
1
Interventions
pembrolizumab
4
Gemcitabine
4
padeliporfin
3
napabucasin
3
Pemetrexed
3
Paclitaxel
3
Drug Therapy
3
Cisplatin
3
Carboplatin
3
130-nm albumin-bound paclitaxel
3
ribociclib
2
palbociclib
2
Mitomycin
2
Gonadotropin-Releasing Hormone
2
Fluorouracil
2
Bevacizumab
2
Anastrozole
2
Albumin-Bound Paclitaxel
2
AZD9833
2
valrubicin
1
selinexor
1
pralsetinib
1
patritumab
1
palladium-bacteriopheophorbide
1
linifanib
1
ipatasertib
1
enfortumab vedotin
1
camrelizumab
1
atezolizumab
1
abemaciclib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Neoplasms by Site
×
Aspirin
×
Clear all
NCT03464305
2024-03-19
ASPIRIN
University Hospital, Antwerp
Phase 3
Active not recruiting
148 enrolled